文献速递妇科生殖医学

七种激素生物标志物诊断子宫内膜异位症:诊断试验准确性的Meta分析与校正间接比较

Seven Hormonal Biomarkers for Diagnosing Endometriosis: Meta-Analysis and Adjusted Indirect Comparison of Diagnostic Test Accuracy.
PubMed 文献 · J Minim Invasive Gynecol · 2019-04-06

该系统评价纳入17项研究共1279名参与者,评估7种激素生物标志物诊断子宫内膜异位症的准确性。芳香化酶汇总敏感度0.79、特异度0.89,优于人绒毛膜促性腺激素/黄体生成素受体、雌激素受体α、雌激素受体β、雌激素磺基转移酶和17β-羟基类固醇脱氢酶2型;与血清催乳素特异度相当但敏感度更低。作者认为芳香化酶可能是优秀诊断试验,但纳入研究质量中等且样本量有限,需更多研究验证。

要点

  • 芳香化酶诊断子宫内膜异位症汇总敏感度0.79、特异度0.89。
  • 血清催乳素汇总敏感度0.45、特异度0.92。
  • 芳香化酶敏感度、特异度、阳性似然比和诊断比值比均高于其他多种标志物。

核心结论

  • 芳香化酶可能是诊断子宫内膜异位症的优良诊断试验。
  • 由于纳入研究质量中等且样本量有限,该结果需更多研究验证。

研究设计与样本

  • 系统检索PubMed、EMBASE、Cochrane图书馆和中国生物医学文献数据库,检索时间从建库至2018年8月。
  • 纳入评估激素标志物诊断子宫内膜异位症准确性的随机对照试验、横断面研究、病例对照研究和队列研究。
  • 共纳入17项研究,涉及1279名参与者,评估7种激素生物标志物。

主要发现

  • 与人绒毛膜促性腺激素/黄体生成素受体、雌激素受体α、雌激素受体β、雌激素磺基转移酶和17β-羟基类固醇脱氢酶2型相比,芳香化酶具有更高的敏感度、特异度、阳性似然比和诊断比值比;芳香化酶与血清催乳素特异度相当,但血清催乳素的敏感度和阳性似然比较芳香化酶低得多。

临床怎么用

  • 作者认为芳香化酶可能是诊断子宫内膜异位症的优良诊断试验。
  • 作者指出因纳入研究质量中等且样本量有限,该结果需更多研究验证。

局限性

  • 纳入研究质量中等。
  • 样本量有限。
  • 该结果需更多研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the diagnostic accuracy of different hormonal biomarkers and to find the most effective hormonal biomarker for the diagnosis of endometriosis. DATA SOURCES: We conducted a systematic search using PubMed, EMBASE, Cochrane Library, and China Biomedical Literature to identify relevant studies from the first day of databases to August 2018. METHODS OF STUDY SELECTION: Two independent reviewers screened for study eligibility and extracted data. Random controlled trials, cross-sectional studies, case-control studies, and cohort studies evaluating the diagnostic accuracy of hormonal markers for endometriosis were included. TABULATION, INTEGRATION, AND RESULTS: We included 17 studies that involved 1279 participants and evaluated 7 hormonal biomarkers. The pooled sensitivity and specificity in endometriosis were .79 (.71, .86) and .89 (.82, .94) for aromatase, .30 (.18, .46) and .80 (.65, .90) for human chorionic gonadotropin/luteinizing hormone receptor, .75 (.66, .83) and .47 (.34, .60) for estrogen receptor (ER)-α, .65 (.56, .74) and .68 (.55, .80) for ER-β, .45 (.38-.52) and .92 (.85-.97) for serum prolactin, .69 (.51, .83) and .30 (.16, .49) for estrogen sulfotransferase, and .73 (.60-.84) and .48 (.33-.63) for 17β-hydroxysteroid dehydrogenase type 2 (17βHSD2). Compared with human chorionic gonadotropin/luteinizing hormone receptor, ER-α, ER-β, estrogen sulfotransferase, and 17βHSD2, aromatase had a higher sensitivity, specificity, positive likelihood ratio, and diagnostic odds ratio. The specificities of aromatase and serum prolactin were comparable, but the sensitivity, positive likelihood ratio, and positive likelihood ratio of serum prolactin were much lower than that of aromatase. CONCLUSION: Aromatase may be an excellent diagnostic test for endometriosis. However, because of the moderate quality of the included studies and the limited sample size, this result requires more research to validate. (PROSPERO registration number: PROSPERO 2018 CRD42018105126.).

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Gao Y, Shen M, Ma X, et al. Seven Hormonal Biomarkers for Diagnosing Endometriosis: Meta-Analysis and Adjusted Indirect Comparison of Diagnostic Test Accuracy. J Minim Invasive Gynecol. 2019. PMID: 30965114. doi:10.1016/j.jmig.2019.04.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。